# ikarovec: Research, Norwich, United Kingdom

> ikarovec: Ikarovec Limited is a UK-based biotechnology company focused on developing novel bicistronic gene therapies for chronic eye diseases, particularly...

Source: https://millionrounds.com/startup/ikarovec (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Research startup](https://millionrounds.com/companies)

# ikarovec

Ikarovec Limited is a UK-based biotechnology company focused on developing novel bicistronic gene therapies for chronic eye diseases, particularly in the field of ophthalmology.

Funding reported Last round: Seed

Research Norwich, United Kingdom

Company summary

- **Founded:** 2018 8 years old
- **Team:** 10 1 to 10 people
- **Funding reported:** 10.3M as listed, currency not stated
- **Last round:** Seed Feb 2020

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for ikarovec has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About ikarovec

Ikarovec Limited is a UK-based biotechnology company focused on developing novel bicistronic gene therapies for chronic eye diseases, particularly in the field of ophthalmology.

Founded in 2018 and headquartered at the Norwich Research Park, Ikarovec aims to enhance long-term sight preservation by providing a single injection that delivers continuous therapeutic effects, reducing the need for repetitive treatments. The company is advancing an early-stage pipeline of AAV-based gene therapies targeting conditions such as Geographic Atrophy, Wet Age-Related Macular Degeneration, and Diabetic Macular Edema. Ikarovec's proprietary platform allows for the expression of two therapeutic proteins from a single vector, addressing multiple disease pathways simultaneously. Their innovative approach is designed to meet the needs of patients suffering from chronic retinal degenerative diseases, ultimately aiming to improve their quality of life by minimizing treatment burdens.

## What company datasets say ikarovec raised

Funding, as reported

Reported in all **10.3M** in the source's currency

Rounds **1**

Last round **Seed**

Last round size **6.5M**

Last round date **Feb 2020**

Investors listed **5**

## Funding filed with regulators

ikarovec filed one raise, $6.5M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Oct 2024 **$6.5M** UK share allotment

## On 3 portfolio pages

Investors who name them

- [LifeArc Ventures](https://millionrounds.com/fund/lifearc-ventures)
- [Future Planet Capital](https://millionrounds.com/fund/future-planet-capital)
- [UK Innovation & Science Seed Fund [UKI2S]](https://millionrounds.com/fund/uk-innovation-and-science-seed-fund)

Each firm lists ikarovec on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care gene therapy for eye diseases biotechnology research long-lasting ophthalmic treatment single injection treatment medical research inflammation reduction gene delivery technology sustained expression bi-functional gene therapy hospital & health care amd treatment medical ophthalmology ocular hypertension gene therapy

Built with from their website

SiteGround SiteGround DNS Google Cloud Hosting Microsoft Exchange Microsoft 365 Apps & Services Microsoft Exchange Online Microsoft 365 Outlook Microsoft Email Providers

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 8731
- **Region:** England
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/ikarovec)

## Research in United Kingdom

Startups like it

- [**Isomorphic Labs** London · founded 2021 *Raised*](https://millionrounds.com/company/isomorphic-labs)
- [**Basecamp Research** London · founded 2019 *Raised*](https://millionrounds.com/company/basecamp-research)
- [**Callosum** London · founded 2025 *Raised*](https://millionrounds.com/company/callosum)
- [**Artios** Babraham · founded 2016 *Raised*](https://millionrounds.com/company/artios)
- [**First Light Fusion** Yarnton · founded 2011 *Raised*](https://millionrounds.com/company/first-light-fusion)
- [**IMU Biosciences** London · founded 2019 *Raised*](https://millionrounds.com/company/imu-biosciences)
- [**Orbital Industries** London · founded 2022 *Raised*](https://millionrounds.com/company/orbital-industries)
- [**Genomics** Oxford · founded 2014 *Raised*](https://millionrounds.com/company/genomics)

## Is this your company?

Add your raise, your deck and your story, and put ikarovec in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)